Cargando…
iTRAQ-based proteomic profiling reveals different protein expression between normal skin and hypertrophic scar tissue
BACKGROUND: A hypertrophic scar is a unique fibrotic disease that only exists in humans. Despite advances in burn care and rehabilitation, as well as progress in the management during these decades, the hypertrophic scar remains hard to cure following surgical methods and drugs for treatment. In thi...
Autores principales: | Tan, Jianglin, He, Weifeng, Luo, Gaoxing, Wu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964291/ https://www.ncbi.nlm.nih.gov/pubmed/27574659 http://dx.doi.org/10.1186/s41038-015-0016-6 |
Ejemplares similares
-
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005) -
Comparative proteomic analysis of extracellular matrix proteins secreted by hypertrophic scar with normal skin fibroblasts
por: Ma, Li, et al.
Publicado: (2014) -
Serum differential proteomic profiling of patients with isolated methylmalonic acidemia by iTRAQ
por: Li, Sitao, et al.
Publicado: (2022) -
Investigating the Role of P311 in the Hypertrophic Scar
por: Tan, Jianglin, et al.
Publicado: (2010) -
iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis
por: Ikeda, Daiki, et al.
Publicado: (2013)